Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Dihexa (PNB-0408) is a synthetic peptide derived from angiotensin IV, developed at Washington State University
A precursor is a building block the body uses to create something else
On the other hand, combining any vasoactive peptide with prescription blood thinners introduces unpredictable interactions
Combined repair-cascade research: The two are most often discussed together precisely because their mechanisms do not overlap, with BPC-157 contributing vascular support and TB-500 contributing cellular migration
While not currently on the WADA list of banned substances (Wada-ama.org 2018), due to what some individuals would term as the synthetic nature of BPC 157, there may be issues associated with the use of this peptide, as seen by some sport organisations
US$ 20.92
US$ 20.97
US$ 27.19
US$ 25.52
